Free Trial

Amgen (AMGN) News Today

Amgen logo
$402.98 -0.06 (-0.01%)
Closing price 04:00 PM Eastern
Extended Trading
$401.50 -1.48 (-0.37%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amgen Latest News

Amgen Inc. $AMGN Shares Sold by CX Institutional
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
Why Amgen's 6% Dividend Raise Masks a Tougher Road Ahead
Why Amgen’s Pipeline Just Got More Interesting
Leerink Partners Remains a Hold on Amgen (AMGN)
Amgen (AMGN) Rises Higher Than Market: Key Facts
Scotiabank Sticks to Its Buy Rating for Amgen (AMGN)
Jefferies Sticks to Their Hold Rating for Amgen (AMGN)
State Street Corp Increases Position in Amgen Inc. $AMGN
Amgen Boasts Success In Sjogren's; Shares Charge Ahead
Amgen's autoimmune drug succeeds in late-stage trial
Biotech Stocks To Consider - September 19th
Nykredit A S Takes Position in Amgen Inc. $AMGN
Barclays Sticks to Its Hold Rating for Amgen (AMGN)
Amgen (AMGN) Gets a Buy from UBS

Amgen Media Mentions By Week

Amgen Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMGN
News Sentiment
▼
0.57

0.43
▲
Average
Healthcare
News Sentiment

Amgen News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMGN Articles
This Week
▼
9

9
▲
AMGN Articles
Average Week

Amgen Trends on MarketBeat

This week vs. last week
New Followers
2
-78%
Searches
5
-17%
Page Views
8,784
-33%
Get Amgen News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Amgen dated 10/5/2026.
From Our Partners